General practitioners’ perspectives, preferences, and practices in prescribing antihypertensive medication in primary, uncomplicated hypertension
Family Practice · 2025
DOI: 10.1093/fampra/cmaf059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Family Practice, 2025. Verfasst von Jakob L Schroevers und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Hypertension, Antihypertensive Agents, Practice Patterns, Physicians', General Practitioners. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Netherlands Organisation for Health Research and Development.
Abstract (Originalsprache)
Background
International guidelines consider most antihypertensive medication (AHM) classes as equivalent options for treating primary hypertension. However, limited research has examined whether general practitioners (GPs) share this view or have specific prescribing preferences. Understanding GPs’ perspectives is crucial for identifying how guidelines are implemented in daily practice. This study explores the perspectives, preferences, and prescribing practices of Dutch GPs regarding AHM classes in patients with primary hypertension who have no cardiovascular comorbidities or diabetes.
Methods
We conducted a qualitative study with semi-structured interviews among Dutch GPs. Interviews were audio-recorded, transcribed verbatim, and thematically analyzed.
Results
We interviewed 18 Dutch GPs (56% female) and identified three key themes: contextual factors when initiating treatment, preferences for AHM classes, and considerations on combination therapy. GPs consider lifestyle modifications, patient age, and initial blood pressure (BP) when deciding on treatment. Most GPs do not view all AHM classes as interchangeable, with their preferences shaped by perceived efficacy, side effects, and patient-specific factors, including ethnicity and patient preferences. GPs often favour a gradual titration approach, starting with one class before adjusting the dosage or adding another.
Conclusion
GPs adopt a multifaceted, patient-centred approach to hypertension, prioritizing lifestyle interventions and weighing short-term risks against long-term benefits. We identified several discrepancies between guideline recommendations and everyday practice—particularly regarding the perceived non-equivalence of AHM classes and limited support for initiating combination therapy. Incorporating GPs’ perspectives into guideline development may lead to more practical, tailored recommendations that improve adherence and patient outcomes in real-world care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Practice, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
- Department of Public and Occupational Health, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
ORCID-Profile: Jakob L Schroevers
Förderung
- Netherlands Organisation for Health Research and Development
Zitieren
APA
Schroevers, J. L., Witvliet, M. P., & Moll van Charante, E. P. (2025). General practitioners’ perspectives, preferences, and practices in prescribing antihypertensive medication in primary, uncomplicated hypertension. Family Practice. https://doi.org/10.1093/fampra/cmaf059
Vancouver
Schroevers JL, Witvliet MP, Moll van Charante EP. General practitioners’ perspectives, preferences, and practices in prescribing antihypertensive medication in primary, uncomplicated hypertension. Family Practice. 2025. doi:10.1093/fampra/cmaf059
BibTeX
@article{Schroevers2025,
author = {Schroevers, Jakob L and Witvliet, Marinho Patrick and Moll van Charante, Eric P},
title = {General practitioners’ perspectives, preferences, and practices in prescribing antihypertensive medication in primary, uncomplicated hypertension},
journal = {Family Practice},
year = {2025},
doi = {10.1093/fampra/cmaf059}
}
EUVIMED